ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AAS Abrdn Asia Focus Plc

282.00
-2.00 (-0.70%)
14 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Abrdn Asia Focus Plc LSE:AAS London Ordinary Share GB00BMF19B58 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.00 -0.70% 282.00 510,705 16:29:56
Bid Price Offer Price High Price Low Price Open Price
281.00 288.00 287.00 282.00 287.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt 45.3M 35.19M 0.2292 12.30 436.07M
Last Trade Time Trade Type Trade Size Trade Price Currency
17:08:33 O 13,000 282.00 GBX

Abrdn Asia Focus (AAS) Latest News (3)

Abrdn Asia Focus (AAS) Discussions and Chat

Abrdn Asia Focus Forums and Chat

Date Time Title Posts
02/10/202408:31Aberdeen Standard Asia Focus PLC77
26/11/201912:00Aberdeen Asian Smaller Com Inv Tst162
08/4/200608:28Aberdeen Asia: Big Discount13

Add a New Thread

Abrdn Asia Focus (AAS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-10-14 16:28:56282.0013,00036,660.00O
2024-10-14 16:15:00281.10125,000351,375.00O
2024-10-14 16:15:00281.60100,000281,600.00O
2024-10-14 16:08:33282.0013,00036,660.00O
2024-10-14 15:46:23281.88130,000366,446.08O

Abrdn Asia Focus (AAS) Top Chat Posts

Top Posts
Posted at 14/10/2024 09:20 by Abrdn Asia Focus Daily Update
Abrdn Asia Focus Plc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker AAS. The last closing price for Abrdn Asia Focus was 284p.
Abrdn Asia Focus currently has 153,546,718 shares in issue. The market capitalisation of Abrdn Asia Focus is £433,001,745.
Abrdn Asia Focus has a price to earnings ratio (PE ratio) of 12.30.
This morning AAS shares opened at 287p
Posted at 23/9/2024 10:14 by davebowler
Fund managers’ report
Market review
Equity markets experienced increased volatility in August, with Asian small caps
rising in US dollar terms by month-end but falling in sterling terms. The first week of
the month saw global markets decline sharply. This sell-off followed the US Federal
Reserve’s (Fed) decision to keep rates unchanged alongside weak labour data,
triggering recession concerns, as well as the unwinding of Japanese yen (JPY)
carry trades after the Bank of Japan’s surprise rate increase led to a sharp rally in
the JPY. Subsequently, however, markets rebounded thanks to more reassuring
economic news in the US, while most Asian currencies rose against the US dollar.
The benchmark MSCI AC Asia Ex Japan Small Cap Index returned -0.10% in sterling
terms, while the Trust outperformed the benchmark by 98 basis points (bps). In
relative terms, our stock selection in India was the leading contributor to returns. Our
above-index exposure to Indonesia was also helpful.
In market news, across the region, Southeast Asia outpaced North Asia and India.
Indonesia, one of Asia's most rate-sensitive stock markets, was boosted by rising
expectations of policy easing by the Fed, while Thai stocks rose on better-thanexpected gross domestic product (GDP) growth. In North Asia, stocks in Hong
Kong outperformed their peers in mainland China, as more resilient earnings lifted
internet names and high-yielding stocks drew interest. The decline in mainland
China came amid mixed economic data. Meanwhile, the market in South Korea was
a key laggard as memory stocks were weighed down partially by concerns over
NVIDIA’s revenue guidance. Elsewhere, Indian stocks rose marginally on the back of
soft quarterly earnings and GDP growth that reached its lowest in five quarters.
At the stock level, the top contributor was South Korea’s Park Systems. The
company, which develops specialised microscopes, rebounded following prior
weakness in a technology led sell-off. In India, KFin Technologies was buoyed
by continued momentum in investor flows and excitement about the potential
for overseas expansion of its core registrar services. The share price of Vijaya
Diagnostic Centre, a leading healthcare services company, hit an all-time high

abrdn Asia Focus plc


in August following robust quarterly results, while Uno Minda, which supplies auto
components to original equipment manufacturers (OEMs), also enjoyed a strong
month. Also in India, Aptus Value Housing Finance India contributed to relative
returns. Its after-tax profit was in line with estimates and investors cheered its focus
on affordable housing, which seem aligned to the government’s priorities following
announcement of India’s most recent Budget. Meanwhile, in Vietnam, FPT Corp, our
software IT conglomerate, pressed on with its good momentum, posting healthy
results. Exposure to Taiwan-listed instrumentation company Chroma ATE and
Taiwan Union Technology Corporation, which produces, copper clad laminates,
also aided returns given outperformance against a weaker Taiwanese market.
Hong Kong’s Dah Sing Financial Holdings Limited was another leading contributor,
with the company releasing good quarterly results towards month-end with a
substantial uplift in their interim dividend.
On the other hand, the leading detractor was India’s Aegis Logistics, which saw
some profit-taking on the back of strong performance in prior months. Another
detractor was India-based APAR Industries, which released numbers that showed
strength in its domestic business but weakness in, exports, particularly to the US. In
the absence of any major launches, India-headquartered Prestige Estates Projects
Ltd reported slower pre-sales. Elsewhere, South Korea’s Hansol Chemical delivered
lower-than-anticipated operating profit due to softness in its precursor and battery
materials segments. Earnings from Leeno Industrial were mixed with revenue that
fell short of consensus due to the slower smartphone market recovery. Although
margins were stronger than predicted, Leeno’s share price slid in August.
In terms of key portfolio activity in August, we initiated a position in Cholamandalam
Financial Holdings a diversified financial services group in India, offering vehicle
finance, home loans, business loans, insurance, and investment services. It has a
strong presence across India with a network of branches and a large customer
base. Among its subsidiaries, Cholamandalam Investment and Finance is a highquality lender in India's informal lending segment.
Another portfolio addition was India's Poly Medicure (PLMD), a founder-owned
business that makes and sells consumable medical devices. PLMD has a broad
product portfolio, with infusion therapy being the largest segment, but it is also
looking to expand further in cardiology and critical care. The company is on track
for double-digit revenue growth in fiscal year 2025 and beyond with management
expecting strong growth in India due to new launches and an expanded marketing
team. It is also investing in several new facilities for export to Europe and the US.
Finally, we exited Bangkok Chain Hospital to fund better opportunities elsewhere.
Outlook
September is historically a difficult month for markets, and the first few days have
borne that out. Technology stocks have become volatile again, after renewed
concerns over AI-related stock valuations. Geopolitics simmer in the background,
as it appears a dead heat for Donald Trump and Vice President Kamala Harris
heading into the US presidential elections in November.
At the same time, US rate cut expectations are rising, which is likely to support
investor appetite in Asia as the US-Asia yield differentials narrow. At the time of
writing, our in-house Global Macro Research team continues to expect 25bp cuts
at each meeting of the US Federal Reserve this year and in the first half of 2025, with
50bp moves on the table in the case of significant growth scares.
Market sentiment is likely to remain volatile over the short term against a stilluncertain backdrop, and we have continued to tighten the quality characteristics of
our portfolio. We maintain our conviction in our holdings and their ability to navigate
the various crosswinds buffeting markets, given their quality and fundamentals
Posted at 30/5/2024 20:32 by davebowler
 Mick Gilligan of Killiks says activists own....36 per cent on Abrdn Asian Focus (AAS)
Posted at 10/5/2024 09:46 by davebowler
Considering the share price of the CULs is only 3% away from being 'in the money' i.e.284/293p = .97 the current price of the CULs at 97p allows for that!
Posted at 10/5/2024 09:34 by davebowler
From LSE -
CULS Holders are reminded that on 4 February 2022 the sub-division of each fully paid ordinary share in the capital of the Company of 25 pence into 5 Ordinary Shares of 5p each, approved by shareholders on 27 January 2022 became effective and, in accordance with the terms of the Trust Deed, the conversion price of the CULS was automatically and pro rata adjusted from 1,465p to 293p.
Posted at 26/4/2024 21:46 by the deacon
I agree. I note that FPT (AAS top holding) signed a deal with Nvidia a couple of days ago. Their stockpicking continues to be excellent
Posted at 28/5/2023 16:15 by loganair
Outside of the important India and Indonesia, for me AAS pips the others to the post - Why?

1. Has the smallest percentage in China, Fidelity Asia has over double the percentage.

2.The largest percentage in Vietnam.

3. I also like how AAS has 9.9% invested in Malaysia and 7.1% in Thailand.

4. How also has none of its investment is in the USA as both Fidelity Asia and Scottish Oriental have.
Posted at 01/6/2022 09:12 by davebowler
AASC gives the right to convert at £2.93 per AAS share up to 2025 and gives downside protection of £1
Posted at 06/5/2022 15:24 by vacendak
I am considering getting into AAS.

I used to own some CULS years ago for Utilico, now UIL Ltd, (UTL) but the rules were simpler than for these with what appear to be floating conversion terms.

Any cheap advice on either buying only AAS or a mix of AAS and AASC?
Posted at 13/1/2022 15:18 by smithie6
RNS today

"Aberdeen Standard Asia Focus plc Including 1616.47p Ordinary
with Debt at Fair Value Income"

Same valuation 2-3 weeks ago was 1680p-1695p

NAV has fallen ~70p but the share price has not.

(I understand that NAV reduces about 10% if the conv. loan notes are converted to shares, so imo the share price is at 0% discount to the NAV....not attractive imo, I am sure that the share price will drift down.
Posted at 12/1/2022 13:04 by smithie6
Interesting

The reported NAV has notably fallen, 60-70p.

But not the share price.
A high chance that the share price will track the NAV & decline a bit.
Abrdn Asia Focus share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock